Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2019-11-15 | 2020-01-06 | 98922 |
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-01-13 | 2020-02-26 | 103178 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Resolved | 2019-12-03 | 2020-03-09 | 100125 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-06-05 | 2019-08-02 | 85629 |
| TOBREX | 0.3% | OINTMENT | Resolved | 2020-09-08 | 2021-02-24 | 123888 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2018-08-24 | 2018-12-13 | 58947 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2022-06-09 | 2022-10-17 | 162289 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2023-04-13 | 2023-05-19 | 189506 |
| GILENYA | 0.25MG | CAPSULE | Resolved | 2023-04-28 | 2023-06-07 | 191077 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2017-11-30 | 2018-01-18 | 31276 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-12-11 | 44015 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Avoided shortage | 2019-01-08 | 2019-04-29 | 71606 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-09-08 | 2020-10-08 | 123880 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-26 | 2020-11-26 | 128967 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |